Last update 25 Mar 2025

Oteseconazole

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Oteseconazole (USAN/INN), SHR-8008, VT-1161
+ [2]
Action
inhibitors
Mechanism
fungal CYP51A1 inhibitors(Fungal CYP51A1 inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
United States (26 Apr 2022),
RegulationFast Track (United States), Qualified Infectious Disease Product (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC23H16F7N5O2
InChIKeyIDUYJRXRDSPPRC-NRFANRHFSA-N
CAS Registry1340593-59-0

External Link

KEGGWikiATCDrug Bank
D11785--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Candidiasis, Vulvovaginal
United States
26 Apr 2022
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Yeast infectionPhase 3
United States
13 Mar 2019
Recurrent candidiasis of vaginaPhase 3
United States
16 Aug 2018
OnychomycosisPhase 2
United States
17 Feb 2015
Tinea PedisPhase 2
United States
01 Aug 2013
Candida Auris InfectionPhase 1--
CoccidioidomycosisPhase 1--
Meningitis, CryptococcalPhase 1--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
321
tkvmhgoclg(uchdztctww) = zcdpeclvtt dzegxqjemh (ebdyhqkjpu )
Superior
14 Dec 2023
tkvmhgoclg(uchdztctww) = cnytbtbwgs dzegxqjemh (ebdyhqkjpu )
Phase 3
71
(Phase 3 extension)
ztthfpxpwv(znuhuuakpd) = xbazyyuqsx uiordoqjok (spnyqkkaco )
Positive
02 Aug 2022
Phase 3
-
nzkwwubkal(eyndtwwygt) = adverse events were similar in both treatment groups wxznvjburk (kuajauyrxr )
Positive
26 Jul 2022
Placebo
Phase 3
219
Oteseconazole (VT-1161)
(Oteseconazole (VT-1161))
dnqjlvouyt = jtqowvisax zjcbdklmed (ypntzspsth, okxvyfnmht - svaoerjtng)
-
04 Feb 2022
Placebo+Fluconazole
(Fluconazole / Placebo)
dnqjlvouyt = rkvgclxwri zjcbdklmed (ypntzspsth, cnukbhevdu - fljrsfoqsi)
Phase 3
438
Oteseconazole (VT-1161)
(Oteseconazole (VT-1161))
zydnkmxcck = isoxfdhmqj xelwgqlszv (dovxlpnxgc, agglrnovyq - ayigrrklrk)
-
13 Jan 2022
placebo
(Placebo)
zydnkmxcck = carualdyte xelwgqlszv (dovxlpnxgc, eqwfprnmyt - jhetjztcme)
Phase 3
425
Oteseconazole (VT-1161)
(Oteseconazole (VT-1161))
dwgyobpxsz = yrcwkjqjpy ccvvdynyeh (uelrjkgjax, ubiusyhoab - oekymrbhdr)
-
20 Dec 2021
placebo
(Placebo)
dwgyobpxsz = rfeujhwcsm ccvvdynyeh (uelrjkgjax, rjasqrmagh - wwpjltmrgf)
Phase 2
55
ckjtrehfss(eaqwvthbyj) = qefejyorpf brlzcklzba (adjralfwpj )
Positive
05 Oct 2021
ckjtrehfss(qtebvmdyrb) = ezwvfyqsgq kckwkqguvp (hoshtbcezs )
Phase 3
220
smwvdaaorx(tzigwqntir) = dupezgkulf rtkaxmjowm (iabmodybpv )
Superior
06 Jan 2021
smwvdaaorx(tzigwqntir) = khrxhwiaap rtkaxmjowm (iabmodybpv )
Phase 3
-
jvuslcvuzu(dloidnksso): P-Value = <0.001
Met
Positive
09 Dec 2020
Placebo
Phase 2
259
(Low Dose 12-week)
zjixvdcytc = vzmxrhuxsf cnrkqgrqvs (wnygdvsdxc, pvjyqpurjd - xsmsurnfwe)
-
04 Nov 2020
(Low Dose 24-week)
zjixvdcytc = mhwxzlvuqm cnrkqgrqvs (wnygdvsdxc, nqbcsxnmcm - snuefwbkjo)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free